1 study found for:    Phase I/II Administration of CMV-specific cytotoxic T cells in patients with Glioblastoma multiforme
Show Display Options
Rank Status Study
1 Terminated Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   GBM;   Brain Cancer
Intervention: Biological: Autologous CMV-specific CTL

Indicates status has not been verified in more than two years